technetium tc 99m sestamibi has been researched along with etoposide in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bom, HS; Kim, JY; Kim, YC; Min, JJ; Park, KO; Song, HC | 1 |
| Bom, HS; Jeong, HJ; Kim, JY; Kim, YC; Lee, J; Lim, SC; Min, JJ; Park, KO; Song, HC | 1 |
| Ichiya, Y; Kuwabara, Y; Maehara, Y; Masuda, K; Nakagawa, M; Sasaki, M; Soeda, H; Sugio, K; Yoshida, T | 1 |
| Hsu, NY; Kao, A; Lee, CC; Lin, CC; Shiun, SC; Sun, SS | 1 |
| Berkarda, S; Cakir, E; Cermik, TF; Doğanay, L; Karlikaya, C; Salan, A; Yüksel, M | 1 |
| Changlai, SP; Ding, HJ; Hsu, WH; Huang, WT; Kao, A; Tsai, CS | 1 |
| Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F | 1 |
| Dechsupa, S; Kothan, S; Leger, G; Mankhetkorn, S; Moretti, JL; Vergote, J | 1 |
| Akgun, A; Burak, Z; Cok, G; Goksel, T; Karapolat, I | 1 |
| Cui, SD; Li, LF; Li, WL; Liu, H; Liu, ZZ; Lu, ZD; Yang, H; Zhang, HW | 1 |
3 trial(s) available for technetium tc 99m sestamibi and etoposide
| Article | Year |
|---|---|
Dipyridamole modulated Tc-99m sestamibi lung SPECT in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Dipyridamole; Drug Resistance, Multiple; Etoposide; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Single-Blind Method; Survival Rate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Turkey | 2006 |
7 other study(ies) available for technetium tc 99m sestamibi and etoposide
| Article | Year |
|---|---|
Technetium-99m-MIBI uptake in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Case-Control Studies; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Prediction of the chemosensitivity of lung cancer by 99mTc-hexakis-2-methoxyisobutyl isonitrile SPECT.
Topics: Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Etoposide; Female; Humans; Lung Neoplasms; Male; Mitomycin; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2003 |
Long-term outcome of oligodendrogliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine | 2004 |
Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells.
Topics: Annexins; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; K562 Cells; Membrane Potentials; Mitochondria; Quercetin; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2004 |
[Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Taxoids; Technetium Tc 99m Sestamibi | 2011 |